The pharmacokinetics and bioavailability of mebendazole in man: a pilot study using [3H]-mebendazole
- PMID: 7126419
- PMCID: PMC1427637
- DOI: 10.1111/j.1365-2125.1982.tb02008.x
The pharmacokinetics and bioavailability of mebendazole in man: a pilot study using [3H]-mebendazole
Abstract
Following the intravenous administration of a tracer dose (1.7 microgram) of [3H]-mebendazole to a man, an elimination half-life of 1.16 h was observed and the volume of distribution was calculated to be 2.03 l/kg. After oral administration of the same dose, an elimination half-life of 0.74 h was observed. The bioavailability of mebendazole from the solution was found to be 17%.
Similar articles
-
The pharmacokinetics and bioavailability of a tracer dose of [3H]-mebendazole in man.Br J Clin Pharmacol. 1985 Jan;19(1):79-86. doi: 10.1111/j.1365-2125.1985.tb02616.x. Br J Clin Pharmacol. 1985. PMID: 3978023 Free PMC article.
-
The metabolic and pharmacokinetic disposition of mebendazole in the rat.Eur J Drug Metab Pharmacokinet. 1983 Oct-Dec;8(4):373-81. doi: 10.1007/BF03188769. Eur J Drug Metab Pharmacokinet. 1983. PMID: 6673974
-
The effect of dose form on the bioavailability of mebendazole in man.Br J Clin Pharmacol. 1985 Jan;19(1):87-90. doi: 10.1111/j.1365-2125.1985.tb02617.x. Br J Clin Pharmacol. 1985. PMID: 3978024 Free PMC article.
-
Clinical pharmacokinetics of mizolastine.Clin Pharmacokinet. 2001;40(7):501-7. doi: 10.2165/00003088-200140070-00002. Clin Pharmacokinet. 2001. PMID: 11510627 Review.
-
[Current status of the chemotherapy of echinococcosis (a review of the literature)].Med Parazitol (Mosk). 1986 Sep-Oct;(5):82-5. Med Parazitol (Mosk). 1986. PMID: 3540563 Review. Russian. No abstract available.
Cited by
-
Biodegradable and biocompatible subcutaneous implants consisted of pH-sensitive mebendazole-loaded/folic acid-targeted chitosan nanoparticles for murine triple-negative breast cancer treatment.J Nanobiotechnology. 2022 Mar 31;20(1):169. doi: 10.1186/s12951-022-01380-2. J Nanobiotechnology. 2022. PMID: 35361226 Free PMC article.
-
Chemotherapy of larval echinococcosis with mebendazole: microsomal liver function and cholestasis as determinants of plasma drug level.Eur J Clin Pharmacol. 1983;25(1):85-90. doi: 10.1007/BF00544021. Eur J Clin Pharmacol. 1983. PMID: 6617731
-
Population Pharmacokinetic-Pharmacodynamic Model of Oxfendazole in Healthy Adults in a Multiple Ascending Dose and Food Effect Study and Target Attainment Analysis.Antimicrob Agents Chemother. 2022 Jan 18;66(1):e0143221. doi: 10.1128/AAC.01432-21. Epub 2021 Oct 4. Antimicrob Agents Chemother. 2022. PMID: 34606333 Free PMC article. Clinical Trial.
-
Enhanced bioavailability and cysticidal effect of three mebendazole-oil preparations in mice infected with secondary cysts of Echinococcus granulosus.Parasitol Res. 2012 Sep;111(3):1205-11. doi: 10.1007/s00436-012-2954-2. Epub 2012 Jun 4. Parasitol Res. 2012. PMID: 22661241
-
Preliminary observations on the biliary elimination of mebendazole and its metabolites in patients with echinococcosis.Eur J Clin Pharmacol. 1983;25(1):81-4. doi: 10.1007/BF00544020. Eur J Clin Pharmacol. 1983. PMID: 6617730
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources